Brief: Egetis Therapeutics Reports Q2 Loss Of SEK 108.9 Million
21/08/2026 06:19
BRIEF-Egetis Therapeutics Reports Q2 Loss Of SEK 108.9 Million Aug 21 (Reuters) - Egetis Therapeutics AB (publ) EGTX.ST:
H1 REVENUE SEK 30.7 MILLION
Q2 REVENUE MSEK 17.4, UP 23% AT CER
Q2 RESULT MSEK -108.9
Source text: ID:nMFNbqVrcg
Further company coverage: EGTX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))